They don't push one outcome
A phase II proof-of-concept trial investigated afatinib in pretreated metastatic ESCC patients with confirmed EGFR overexpression
[16] [18] Current clinical guidelines recommend caution and individualized decision-making, given the lack of robust safety data for high-dose injectable vitamin C in pregnancy and lactation
, 21 , 396-413, doi: Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., and Wu, G
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis
Copper peptide for face and GHK-Cu for acne scars are often searched